P124 Differences in OSA pathophysiological traits between mandibular advancement therapy responders versus non-responses and the influence of obesity

Mandibular advancement therapy (MAS) is a recognised second-line therapy for obstructive sleep apnoea (OSA). However, MAS treatment outcomes vary and are difficult to predict. Recent studies have investigated the role of OSA endotypes to predict MAS therapy outcomes. However, whether OSA endotype pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, B, Chiang, A, Naik, G, Osman, A, Bull, C, Donegan, M, Pinczel, A, Rawson, G, Pitcher, G, Brown, E, Kwan, B, Mukherjee, S, Adams, R, Eckert, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108956/
http://dx.doi.org/10.1093/sleepadvances/zpac029.192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108956/
http://dx.doi.org/10.1093/sleepadvances/zpac029.192

Ejemplares similares